A subsidized insurance program designed to ensure equitable access to synthetic organs for individuals across all socioeconomic strata. Funded by a combination of government subsidies, industry contributions, and tiered premiums, it aims to reduce disparities in healthcare access driven by the growth of the synthetic organ market.